Daniel Regan
2014
In 2014, Daniel Regan earned a total compensation of $1.2M as Former Chief Commercial Officer at Intercept Pharmaceuticals, a 72% decrease compared to previous year.
Compensation breakdown
| Bonus | $129,600 |
|---|---|
| Option Awards | $332,701 |
| Salary | $372,500 |
| Stock Awards | $375,074 |
| Other | $21,720 |
| Total | $1,231,595 |
Regan received $375.1K in stock awards, accounting for 30% of the total pay in 2014.
Regan also received $129.6K in bonus, $332.7K in option awards, $372.5K in salary and $21.7K in other compensation.
Rankings
In 2014, Daniel Regan's compensation ranked 6,652nd out of 13,032 executives tracked by ExecPay. In other words, Regan earned more than 49.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,652 out of 13,032 | 49th |
Division Manufacturing | 2,429 out of 4,966 | 51st |
Major group Chemicals And Allied Products | 819 out of 1,686 | 51st |
Industry group Drugs | 642 out of 1,365 | 53rd |
Industry Pharmaceutical Preparations | 489 out of 1,043 | 53rd |
Source: SEC filing on June 20, 2016.
Regan's colleagues
We found four more compensation records of executives who worked with Daniel Regan at Intercept Pharmaceuticals in 2014.